全文获取类型
收费全文 | 10205篇 |
免费 | 645篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 373篇 |
妇产科学 | 155篇 |
基础医学 | 1137篇 |
口腔科学 | 345篇 |
临床医学 | 698篇 |
内科学 | 2396篇 |
皮肤病学 | 231篇 |
神经病学 | 502篇 |
特种医学 | 345篇 |
外科学 | 1362篇 |
综合类 | 186篇 |
一般理论 | 5篇 |
预防医学 | 586篇 |
眼科学 | 485篇 |
药学 | 968篇 |
中国医学 | 51篇 |
肿瘤学 | 978篇 |
出版年
2023年 | 50篇 |
2022年 | 108篇 |
2021年 | 254篇 |
2020年 | 137篇 |
2019年 | 190篇 |
2018年 | 250篇 |
2017年 | 161篇 |
2016年 | 192篇 |
2015年 | 254篇 |
2014年 | 329篇 |
2013年 | 418篇 |
2012年 | 616篇 |
2011年 | 655篇 |
2010年 | 322篇 |
2009年 | 333篇 |
2008年 | 464篇 |
2007年 | 488篇 |
2006年 | 499篇 |
2005年 | 444篇 |
2004年 | 418篇 |
2003年 | 391篇 |
2002年 | 362篇 |
2001年 | 294篇 |
2000年 | 311篇 |
1999年 | 226篇 |
1998年 | 112篇 |
1997年 | 78篇 |
1996年 | 72篇 |
1995年 | 79篇 |
1994年 | 50篇 |
1993年 | 54篇 |
1992年 | 161篇 |
1991年 | 165篇 |
1990年 | 160篇 |
1989年 | 141篇 |
1988年 | 146篇 |
1987年 | 168篇 |
1986年 | 139篇 |
1985年 | 115篇 |
1984年 | 118篇 |
1983年 | 85篇 |
1982年 | 57篇 |
1979年 | 66篇 |
1977年 | 57篇 |
1976年 | 60篇 |
1975年 | 57篇 |
1974年 | 81篇 |
1973年 | 65篇 |
1972年 | 55篇 |
1971年 | 51篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
Maxadilan is a vasodilator peptide isolated from sand fly salivary glands. The vasodilator effects of maxadilan are mediated by the PAC1 receptor, although maxadilan and PACAP do not share sequence homology. Sand flies are the vector of the parasitic disease leishmaniasis. The peptide aids the sand fly in obtaining a blood meal while enhancing the infectivity of leishmania parasites transmitted by this arthropod vector. Aspects of maxadilan, PAC1, and leishmaniasis are discussed. 相似文献
992.
993.
994.
995.
996.
The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cross-activation between beta3 integrin and tyrosine kinase receptor 2 for vascular endothelial growth factor (VEGF) receptor (VEGFR-2) on endothelium. The relationship between VEGFR-2 and beta3 integrin appears to be synergistic, because VEGFR-2 activation induces beta3 integrin tyrosine phosphorylation, which, in turn, is crucial for VEGF-induced tyrosine phosphorylation of VEGFR-2. We demonstrate here that adhesion- and growth factor-induced beta3 integrin tyrosine phosphorylation are directly mediated by c-Src. VEGF-stimulated recruitment and activation of c-Src and subsequent beta3 integrin tyrosine phosphorylation are critical for interaction between VEGFR-2 and beta3 integrin. Moreover, c-Src mediates growth factor-induced beta3 integrin activation, ligand binding, beta3 integrin-dependent cell adhesion, directional migration of endothelial cells, and initiation of angiogenic programming in endothelial cells. Thus, the present study determines the molecular mechanisms and consequences of the synergism between 2 cell surface receptor systems, growth factor receptor and integrins, and opens new avenues for the development of pro- and antiangiogenic strategies. 相似文献
997.
Signature abnormalities in the cell cycle and apoptotic pathway have been identified in mantle cell lymphoma (MCL), affording the opportunity to develop targeted therapies. In this study, we tested a novel class of kinase inhibitors, styryl sulfones, which differ from prior cell cycle inhibitors in that they are not related to purines or pyrimidines. We observed that two closely related compounds, ON013100 and ON01370, altered the growth and cell cycle status of MCL lines and potently inhibited the expression of several important molecules, including cyclin-dependent kinase 4, p53, mouse double minute 2 (MDM2), and cyclin D as well as increased cyclin B expression. Using both terminal deoxy transferase uridine triphosphate nick end-labelling and poly ADP-ribose polymerase assays, we found that these compounds caused apoptosis in MCL cells. In addition, using molecular analyses, we observed the modulation of caspase-3 activity but not the expression of B-cell lymphoma family molecules. Next, we investigated the cytotoxicity of the MCL lines upon treatment with styryl sulfone compounds in combination with other currently used chemotherapeutic agents, such as doxorubicin (DOX) or vincristine (VCR). We found that the combination of DOX plus styryl sulfone or VCR plus styryl sulfone increased cytotoxicity by one log scale, compared with the single styryl sulfone compound. Thus, styryl sulfones alone, or in combination with chemotherapeutic agents, present attractive opportunities for new drug development in MCL. 相似文献
998.
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation 总被引:1,自引:0,他引:1
Kitisin K Ganesan N Tang Y Jogunoori W Volpe EA Kim SS Katuri V Kallakury B Pishvaian M Albanese C Mendelson J Zasloff M Rashid A Fishbein T Evans SR Sidawy A Reddy EP Mishra B Johnson LB Shetty K Mishra L 《Oncogene》2007,26(50):7103-7110
Transforming growth factor-beta (TGF-beta) signaling members, TGF-beta receptor type II (TBRII), Smad2, Smad4 and Smad adaptor, embryonic liver fodrin (ELF), are prominent tumor suppressors in gastrointestinal cancers. Here, we show that 40% of elf(+/-) mice spontaneously develop hepatocellular cancer (HCC) with markedly increased cyclin D1, cyclin-dependent kinase 4 (Cdk4), c-Myc and MDM2 expression. Reduced ELF but not TBRII, or Smad4 was observed in 8 of 9 human HCCs (P<0.017). ELF and TBRII are also markedly decreased in human HCC cell lines SNU-398 and SNU-475. Restoration of ELF and TBRII in SNU-398 cells markedly decreases cyclin D1 as well as hyperphosphorylated-retinoblastoma (hyperphosphorylated-pRb). Thus, we show that TGF-beta signaling and Smad adaptor ELF suppress human hepatocarcinogenesis, potentially through cyclin D1 deregulation. Loss of ELF could serve as a primary event in progression toward a fully transformed phenotype and could hold promise for new therapeutic approaches in human HCCs. 相似文献
999.
1000.
Gaspar NJ Li L Kapoun AM Medicherla S Reddy M Li G O'Young G Quon D Henson M Damm DL Muiru GT Murphy A Higgins LS Chakravarty S Wong DH 《Molecular pharmacology》2007,72(1):152-161
Transforming growth factor beta (TGFbeta) is a pleiotropic factor that regulates cell proliferation, angiogenesis, metastasis, and immune suppression. Dysregulation of the TGFbeta pathway in tumor cells often leads to resistance to the antiproliferative effects of TGFbeta while supporting other cellular processes that promote tumor invasiveness and growth. In the present study, SD-208, a 2,4-disubstituted pteridine, ATP-competitive inhibitor of the TGFbeta receptor I kinase (TGFbetaRI), was used to inhibit cellular activities and tumor progression of PANC-1, a human pancreatic tumor line. SD-208 blocked TGFbeta-dependent Smad2 phosphorylation and expression of TGFbeta-inducible proteins in cell culture. cDNA microarray analysis and functional gene clustering identified groups of TGFbeta-regulated genes involved in metastasis, angiogenesis, cell proliferation, survival, and apoptosis. These gene responses were inhibited by SD-208. Using a Boyden chamber motility assay, we demonstrated that SD-208 inhibited TGFbeta-stimulated invasion in vitro. An orthotopic xenograft mouse model revealed that SD-208 reduced primary tumor growth and decreased the incidence of metastasis in vivo. Our findings suggest mechanisms through which TGFbeta signaling may promote tumor progression in pancreatic adenocarcinoma. Moreover, they suggest that inhibition of TGFbetaRI with a small-molecule inhibitor may be effective as a therapeutic approach to treat human pancreatic cancer. 相似文献